Robert J. Marshall, Jr. is a seasoned financial executive who currently serves as the Chief Financial Officer (CFO) and Treasurer at Lantheus Holdings, Inc., a position he has held since 2016. Lantheus Holdings is a leading radiopharmaceutical-focused company committed to improving patient outcomes through the development, manufacture, and commercialization of innovative diagnostic and therapeutic products. In his role as CFO and Treasurer, Marshall is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His strategic leadership has been instrumental in driving Lantheus' growth and financial performance, positioning the company as a key player in the radiopharmaceutical industry. Prior to joining Lantheus Holdings, Marshall held several senior financial positions at various healthcare and life sciences companies. He served as the CFO of ZELTIQ Aesthetics, Inc., a medical technology company focused on developing and commercializing non-invasive body contouring treatments. During his tenure at ZELTIQ, Marshall played a crucial role in the company's successful initial public offering (IPO) and subsequent growth. Before ZELTIQ, he was the CFO of Fougera Pharmaceuticals, a leading specialty pharmaceutical company, where he led the company through a period of significant growth and profitability. Marshall's extensive experience in the healthcare and life sciences sectors, combined with his strong financial acumen, has enabled him to make significant contributions to Lantheus Holdings' success. Marshall holds a Bachelor of Science degree in Business Administration from the University of Vermont and an MBA from Bentley University. Throughout his career, he has demonstrated a commitment to driving operational excellence and financial discipline, which has been recognized by his peers and the industry. Under his leadership, Lantheus Holdings has achieved strong financial results and continued to invest in research and development to bring innovative products to market. Marshall's strategic vision and financial expertise have been vital in positioning Lantheus Holdings for long-term success and growth in the radiopharmaceutical industry.